Companies / Structure Therapeutics Inc.
Structure Therapeutics Inc.
Nasdaq: GPCRCIK 1888886SOUTH SAN FRANCISCO, CA
Financials
Ownership
213.9M shares outstanding · as of Jul 31, 2026
Ownership
| 10%+ / strategic | 20.31% | 43,447,980 |
| Institutions | 25.06% | 53,613,113 |
| Public float | 54.63% | 116,868,479 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 12
View all →| Insider | % of shares | Shares |
|---|---|---|
Berrios John JosephFormerChief Commercial Officer | — | — |
Coll Crespo BlasFormerCHIEF MEDICAL OFFICER | — | — |
Dobmeier EricDirector | — | — |
Fmr LLC10% owner | — | — |
Hall AshleyFormerChief Development Officer | — | — |
Lin XichenCHIEF SCIENTIFIC OFFICER | — | — |
Love Ted WDirector | — | — |
Ma YingliCHIEF TECHNOLOGY OFFICER | — | — |
Stevens Raymond CCEOCHIEF EXECUTIVE OFFICER · Director | — | — |
Tetlow SharonDirector | — | — |
Institutional holders 203
View all →| Holder | Value | % of shares |
|---|---|---|
| $605.94M | 4.07% | |
| $495.33M | 3.33% | |
| $455.94M | 3.06% | |
| $285.97M | 1.92% | |
| $258.26M | 2.50% | |
| $166.74M | 1.62% | |
| $145.21M | 0.98% | |
| $114.23M | 0.77% | |
| $84.53M | 0.82% | |
| $81.72M | 0.55% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2025 as of | Farallon Capital Management LLC 13F manager | New | ADR | $31.58M | +454K | 454,000 0.21% of shares | medium |
| Q2 2026 as of | Deutsche Bank AG 13F manager | Trim | ADR | $-27.33M | -509K -60.55% | 331,867 0.16% of shares | medium |
| Q1 2026 as of | Principal Financial Group Inc 13F manager | Add | ADR | $22.63M | +470K +36.56% | 1,753,764 0.82% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | Add | ADR | $15.12M | +314K +26.99% | 1,475,403 0.69% of shares | medium |
| Q1 2026 as of | AllianceBernstein L.P. 13F manager | Trim | ADR | $-14.61M | -210K -24.74% | 638,813 0.30% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | ADR | $12.77M | +265K +5.20% | 5,354,981 2.50% of shares | medium |
| Q1 2026 as of | D. E. Shaw & Co., Inc. 13F manager | Add | ADR | $9.46M | +196K +2274.93% | 204,790 0.10% of shares | medium |
| Q4 2025 as of | Boxer Capital Management, LLC 13F manager | New | ADR | $5.22M | +75K | 75,000 0.04% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Deep Track Capital, LP | Passive13G/A | — |
| Fmr LLC | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Biotechnology Value Fund L P | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| GPCR | ADR | 86366E106 |